CANTHANOX, a randomised controlled study comparing low molecular weight heparin and warfarin for the long term treatment of venous thromboembolism in patients with cancer

15 Aout 2002 Par – G. Meyer, Z. Marjanovic, J. Valcke, B. Lorcerie, Y. Gruel, P. Solal-Celigny, C. Lemaignan, J.M. Extra, P. Cottu, D. Farge. CANTHANOX, a randomised controlled study comparing low molecular weight heparin and warfarin for the long term treatment of venous thromboembolism in patients with cancer. Archives of Internal Medicine 2002; 162:1729-1735 Download (PDF, 104KB) streaming Nightcrawler 2014 movie
Plus